~67 spots leftby Oct 2025

AI Chatbot for Osteoarthritis

(CHAT-OA Trial)

Recruiting in Palo Alto (17 mi)
ZC
Overseen byZachary C Lum, DO
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of California, Davis
No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to assess the use of a generative artificial intelligence large language model chatbot in improving decision making factors in patients with hip and knee osteoarthritis. The main questions it aims to answer are: Does the use of an artificial intelligence chatbot have an effect on decisional conflict and anxiety related to decision making? Are changes in decisional conflict correlated with changes in patient reported outcomes? Are changes in decisional conflict correlated with health literacy? Participants will interact with an artificial intelligence chatbot prior to their clinic visit with an orthopaedic surgeon, using a structured prompt.

Research Team

ZC

Zachary C Lum, DO

Principal Investigator

University of California, Davis

Eligibility Criteria

This trial is for individuals with hip or knee osteoarthritis who are facing decisions about their healthcare. They should be comfortable interacting with an AI chatbot before meeting with an orthopedic surgeon.

Inclusion Criteria

Ability to read and write in English
I am 18 years old or older.
All races and ethnicities
See 1 more

Exclusion Criteria

Inability to read and write in English

Treatment Details

Interventions

  • Artificial Intelligence Chatbot (AI Technology)
Trial OverviewThe study tests if a conversational AI chatbot can help reduce decisional conflict and anxiety in patients, improve patient outcomes, and enhance health literacy regarding treatment options for osteoarthritis.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Artificial Intelligence ChatbotExperimental Treatment1 Intervention
This arm will interact with an artificial intelligence chatbot prior to their clinic visit.
Group II: Standard of careActive Control1 Intervention
This arm will undergo standard clinical care without the intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Davis

Lead Sponsor

Trials
958
Recruited
4,816,000+
Rakesh Dixit profile image

Rakesh Dixit

University of California, Davis

Chief Executive Officer since 2024

PhD in Biochemistry and Molecular Biology from the University of California, Davis

Suresh Mahabhashyam profile image

Suresh Mahabhashyam

University of California, Davis

Chief Medical Officer since 2020

MD from Bangalore Medical College